Bioapter
We develop aptamers for research and diagnosis as an alternative or complement to antibodies.
Aptamers
They constitute a new technology that is revolutionizing the research and diagnosis fields. They are short DNA or RNA sequences that bind with high affinity and specificity to all kind of targets, small molecules, peptides, proteins, cells and microorganisms.
Solution
Aptamers provide an additional tool in the molecular research, diagnostics and therapy toolkit. Aptamers solve the problems that certain targets or antibodies may present at a very competitive cost.
Bioapter directs its development and innovation capacity towards three main lines of interest:
- Development of biosensors based on aptamers in collaboration with leading companies in the sector.
- Commercialization of aptamers internally developed by Bioapter.
- Aptamer development projects for our clients.